Impact of the New Delhi metallo-beta-lactamase on beta-lactam antibiotics

Infection and Drug Resistance

Volumn 8, Issue , 2015, Pages 297-309

  Zmarlicka, Monika T ^a   Nailor, Michael D ^b   Nicolau, David P ^a  

^a HARTFORD HOSPITAL   (United States)

^b UNIVERSITY OF CONNECTICUT   (United States)

Author keywords

Carbapenemase; Metallo beta lactamase; Resistance

Indexed keywords

AMOXICILLIN PLUS CLAVULANIC ACID; AMPICILLIN; AVIBACTAM; AZTREONAM; BETA LACTAM ANTIBIOTIC; CARBAPENEM; CARBAPENEMASE; CEFOPERAZONE PLUS SULBACTAM; CEFTAZIDIME; CEFTRIAXONE; CEFUROXIME; CEPHALOSPORIN; DORIPENEM; ERTAPENEM; FLUCLOXACILLIN; IMIPENEM; MEROPENEM; METALLO BETA LACTAMASE; NEW DELHI METALLO BETA LACTAMASE; PENICILLIN G; PIPERACILLIN; PIPERACILLIN PLUS TAZOBACTAM; SULTAMICILLIN; UNCLASSIFIED DRUG;

ACINETOBACTER; ACINETOBACTER BAUMANNII; ACINETOBACTER PITTII; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; BACTERIAL INFECTION; BACTERIUM CULTURE; BACTERIUM ISOLATE; CHRYSEOBACTERIUM INDOLOGENES; CITROBACTER FREUNDII; DRUG HYDROLYSIS; ENTEROBACTER CLOACAE; ENTEROCOCCUS FAECALIS; ENZYME ASSAY; ESCHERICHIA COLI; GENE IDENTIFICATION; HUMAN; IN VITRO STUDY; IN VIVO STUDY; INDIA; KLEBSIELLA PNEUMONIAE; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; MINIMUM INHIBITORY CONCENTRATION; MORGANELLA MORGANII; NONHUMAN; PHENOTYPE; PROVIDENCIA RETTGERI; PSEUDOMONAS AERUGINOSA; REVIEW;

EID: 84940905795     PISSN: None     EISSN: 11786973     Source Type: Journal    
DOI: 10.2147/IDR.S39186     Document Type: Review

References (65)

1. Queenan AM, Bush K. Carbapenemases: the versatile beta-lactamases. Clin Microbiol Rev. 2007;20(3):440-458.
2. Cornaglia G, Giamarellou H, Rossolini GM. Metallo-beta-lactamases: a last frontier for beta-lactams? Lancet Infect Dis. 2011;11(5):381-393.
3. Yong D, Toleman MA, Giske CG, et al. Characterization of a new metallo-beta-lactamase gene, bla(NDM-1), and a novel erythromycin esterase gene carried on a unique genetic structure in Klebsiella pneumoniae sequence type 14 from India. Antimicrob Agents Chemother. 2009;53(12):5046-5054.
4. Dortet L, Poirel L, Nordmann P. Worldwide dissemination of the NDM-type carbapenemases in gram-negative bacteria. Biomed Res Int. 2014;2014:249856.
5. Wang X, Li H, Zhao C, et al. Novel NDM-9 metallo-beta-lactamase identified from a ST107 Klebsiella pneumoniae strain isolated in China. Int J Antimicrob Agents. 2014;44(1):90-91.
6. Zou D, Huang Y, Zhao X, et al. A novel New Delhi metallo-beta-lactamase variant, NDM-14, isolated in a Chinese hospital possesses increased enzymatic activity against carbapenems. Antimicrob Agents Chemother. 2015;59(4):2450-2453.
7. Nordmann P, Boulanger AE, Poirel L. NDM-4 metallo-beta-lactamase with increased carbapenemase activity from Escherichia coli. Antimicrob Agents Chemother. 2012;56(4):2184-2186.
8. Castanheira M, Deshpande LM, Farrell SE, Shetye S, Shah N, Jones RN. Update on the prevalence and genetic characterization of NDM-1-producing Enterobacteriaceae in Indian hospitals during 2010. Diagn Microbiol Infect Dis. 2013;75(2):210-213.
9. Biedenbach D, Bouchillon S, Hackel M, et al. Dissemination of NDM metallo-beta-lactamase genes among clinical isolates of Enterobacteriaceae collected during the SMART global surveillance study from 2008 to 2012. Antimicrob Agents Chemother. 2015;59(2):826-830.
10. Kumarasamy KK, Toleman MA, Walsh TR, et al. Emergence of a new antibiotic resistance mechanism in India, Pakistan, and the UK: a molecular, biological, and epidemiological study. Lancet Infect Dis. 2010;10(9):597-602.
11. Mizuno Y, Yamaguchi T, Matsumoto T. A first case of New Delhi metallo-beta-lactamase-7 in an Escherichia coli ST648 isolate in Japan. J Infect Chemother. 2014;20(12):814-816.
12. Halaby T, Reuland AE, Al Naiemi N, et al. A case of New Delhi metallo-beta-lactamase 1 (NDM-1)-producing Klebsiella pneumoniae with putative secondary transmission from the Balkan region in the Netherlands. Antimicrob Agents Chemother. 2012;56(5):2790-2791.
13. Poirel L, Lagrutta E, Taylor P, Pham J, Nordmann P. Emergence of metallo-beta-lactamase NDM-1-producing multidrug-resistant Escherichia coli in Australia. Antimicrob Agents Chemother. 2010; 54(11):4914-4916.
14. Tzouvelekis LS, Markogiannakis A, Psichogiou M, Tassios PT, Daikos GL. Carbapenemases in Klebsiella pneumoniae and other Enterobacteriaceae: an evolving crisis of global dimensions. Clin Microbiol Rev. 2012;25(4): 682-707.
15. Miriagou V, Cornaglia G, Edelstein M, et al. Acquired carbapenemases in gram-negative bacterial pathogens: detection and surveillance issues. Clin Microbiol Infect. 2010;16(2):112-122.
16. Nordmann P, Poirel L, Dortet L. Rapid detection of carbapenemase-producing Enterobacteriaceae. Emerg Infect Dis. 2012;18(9): 1503-1507.
17. Clinical and Laboratory Standards Institute [Internet page]. CLSI Publishes New Antimicrobial Susceptibility Testing Standards. 2015. Available from: http://clsi.org/blog/2015/01/08/clsi-publishes-new-antimicrobial-susceptibility-testing-standards/. Accessed May 8, 2015.
18. Datta S, Roy S, Chatterjee S, et al. A five-year experience of carbapenem resistance in Enterobacteriaceae causing neonatal septicaemia: predominance of NDM-1. PLoS One. 2014;9(11):e112101.
19. Daikos GL, Petrikkos P, Psichogiou M, et al. Prospective observational study of the impact of VIM-1 metallo-beta-lactamase on the outcome of patients with Klebsiella pneumoniae bloodstream infections. Antimicrob Agents Chemother. 2009;53(5):1868-1873.
20. Munoz-Price LS, Poirel L, Bonomo RA, et al. Clinical epidemiology of the global expansion of Klebsiella pneumoniae carbapenemases. Lancet Infect Dis. 2013;13(9):785-796.
21. Chihara S, Okuzumi K, Yamamoto Y, Oikawa S, Hishinuma A. First case of New Delhi metallo-beta-lactamase 1-producing Escherichia coli infection in Japan. Clin Infect Dis. 2011;52(1):153-154.
22. Pasteran F, Mora MM, Albornoz E, et al. Emergence of genetically unrelated NDM-1-producing Acinetobacter pittii strains in Paraguay. J Antimicrob Chemother. 2014;69(9):2575-2578.
23. Sidjabat H, Nimmo GR, Walsh TR, et al. Carbapenem resistance in Klebsiella pneumoniae due to the New Delhi metallo-beta-lactamase. Clin Infect Dis. 2011;52(4):481-484.
24. Seija V, Medina Presentado JC, Bado I, et al. Sepsis caused by New Delhi metallo-beta-lactamase (blaNDM-1) and qnrD-producing Morganella morganii, treated successfully with fosfomycin and meropenem: case report and literature review. Int J Infect Dis. 2015;30:20-26.
25. Flateau C, Janvier F, Delacour H, et al. Recurrent pyelonephritis due to NDM-1 metallo-beta-lactamase producing Pseudomonas aeruginosa in a patient returning from Serbia, France, 2012. Euro Surveill. 2012; 17(45):20311.
26. Nagar A, Yew P, Ong G, et al. Two cases of importation of New Delhi metallo-beta-lactamase 1 into Northern Ireland. Ulster Med J. 2012; 81(3):154-155.
27. Stone NR, Woodford N, Livermore DM, et al. Breakthrough bacteraemia due to tigecycline-resistant Escherichia coli with New Delhi metallo-beta-lactamase (NDM)-1 successfully treated with colistin in a patient with calciphylaxis. J Antimicrob Chemother. 2011;66(11): 2677-2678.
28. Chien JM, Koh TH, Chan KS, Chuah TH, Tan TT. Successful treatment of NDM-1 Klebsiella pneumoniae bacteraemia in a neutropenic patient. Scand J Infect Dis. 2012;44(4):312-314.
29. Pasteran F, Albornoz E, Faccone D, et al. Emergence of NDM-1-producing Klebsiella pneumoniae in Guatemala. J Antimicrob Chemother. 2012;67(7):1795-1797.
30. Escobar Pérez JA, Olarte Escobar NM, Castro-Cardozo B, et al. Outbreak of NDM-1-producing Klebsiella pneumoniae in a neonatal unit in Colombia. Antimicrob Agents Chemother. 2013;57(4):1957-1960.
31. Pannaraj PS, Bard JD, Cerini C, Weissman SJ. Pediatric carbapenem-resistant Enterobacteriaceae in Los Angeles, California, a high-prevalence region in the United States. Pediatr Infect Dis J. 2015;34(1): 11-16.
32. Samuelsen O, Thilesen CM, Heggelund L, Vada AN, Kummel A, Sundsfjord A. Identification of NDM-1-producing Enterobacteriaceae in Norway. J Antimicrob Chemother. 2011;66(3):670-672.
33. Poirel L, Ros A, Carricajo A, et al. Extremely drug-resistant Citrobacter freundii isolate producing NDM-1 and other carbapenemases identified in a patient returning from India. Antimicrob Agents Chemother. 2011;55(1):447-448.
34. Kulkova N, Babalova M, Sokolova J, Krcmery V. First report of New Delhi metallo-beta-lactamase-1-producing strains in Slovakia. Microb Drug Resist. 2015;21(1):117-120.
35. Chan HL, Poon LM, Chan SG, Teo JW. The perils of medical tourism: NDM-1-positive Escherichia coli causing febrile neutropenia in a medical tourist. Singapore Med J. 2011;52(4):299-302.
36. Carattoli A, Fortini D, Galetti R, et al. Isolation of NDM-1-producing Pseudomonas aeruginosa sequence type ST235 from a stem cell transplant patient in Italy, May 2013. Euro Surveill. 2013;18(46):20633.
37. Poirel L, Ozdamar M, Ocampo-Sosa AA, Turkoglu S, Ozer UG, Nordmann P. NDM-1-producing Klebsiella pneumoniae now in Turkey. Antimicrob Agents Chemother. 2012;56(5):2784-2785.
38. Drawz SM, Papp-Wallace KM, Bonomo RA. New beta-lactamase inhibitors: a therapeutic renaissance in an MDR world. Antimicrob Agents Chemother. 2014;58(4):1835-1846.
39. Livermore DM, Mushtaq S, Warner M, et al. Activities of NXL104 combinations with ceftazidime and aztreonam against carbapenemase-producing Enterobacteriaceae. Antimicrob Agents Chemother. 2011; 55(1):390-394.
40. Docobo-Pérez F, Nordmann P, Domínguez-Herrera J, et al. Efficacies of colistin and tigecycline in mice with experimental pneumonia due to NDM-1-producing strains of Klebsiella pneumoniae and Escherichia coli. Int J Antimicrob Agents. 2012;39(3):251-254.
41. Jain A, Hopkins KL, Turton J, et al. NDM carbapenemases in the United Kingdom: an analysis of the first 250 cases. J Antimicrob Chemother. 2014;69(7):1777-1784.
42. Kaase M, Szabados F, Anders A, Gatermann SG. Fosfomycin susceptibility in carbapenem-resistant Enterobacteriaceae from Germany. J Clin Microbiol. 2014;52(6):1893-1897.
43. Sutcliffe JA, O'Brien W, Fyfe C, Grossman TH. Antibacterial activity of eravacycline (TP-434), a novel fluorocycline, against hospital and community pathogens. Antimicrob Agents Chemother. 2013;57(11): 5548-5558.
44. Tetraphase Pharmaceuticals Pipeline: Eravacycline [Internet page]. Tetraphase Pharmaceuticals. Accessed from: http://tphase.com/pipeline/eravacycline. Accessed May 7, 2015.
45. Tangden T, Hickman RA, Forsberg P, Lagerback P, Giske CG, Cars O. Evaluation of double- and triple-antibiotic combinations for VIM- and NDM-producing Klebsiella pneumoniae by in vitro time-kill experiments. Antimicrob Agents Chemother. 2014;58(3):1757-1762.
46. Bercot B, Poirel L, Dortet L, Nordmann P. In vitro evaluation of antibiotic synergy for NDM-1-producing Enterobacteriaceae. J Antimicrob Chemother. 2011;66(10):2295-2297.
47. Albur M, Noel A, Bowker K, MacGowan A. Bactericidal activity of multiple combinations of tigecycline and colistin against NDM-1-producing Enterobacteriaceae. Antimicrob Agents Chemother. 2012;56(6):3441-3443.
48. MacVane SH, Crandon JL, Nichols WW, Nicolau DP. Unexpected in vivo activity of ceftazidime alone and in combination with avibactam against New Delhi metallo-beta-lactamase-producing Enterobacteriaceae in a murine thigh infection model. Antimicrob Agents Chemother. 2014;58(11):7007-7009.
49. Wiskirchen DE, Nordmann P, Crandon JL, Nicolau DP. Efficacy of humanized carbapenem exposures against New Delhi metallo-beta-lactamase (NDM-1)-producing Enterobacteriaceae in a murine infection model. Antimicrob Agents Chemother. 2013;57(8):3936-3940.
50. Wiskirchen DE, Nordmann P, Crandon JL, Nicolau DP. In vivo efficacy of human simulated regimens of carbapenems and comparator agents against NDM-1-producing Enterobacteriaceae. Antimicrob Agents Chemother. 2014;58(3):1671-1677.
51. Crandon JL, Nicolau DP. Human simulated studies of aztreonam and aztreonam-avibactam to evaluate activity against challenging gram-negative organisms, including metallo-beta-lactamase producers. Antimicrob Agents Chemother. 2013;57(7):3299-3306.
52. Oteo J, Domingo-García D, Fernández-Romero S, et al. Abdominal abscess due to NDM-1-producing Klebsiella pneumoniae in Spain. J Med Microbiol. 2012;61(pt 6):864-867.
53. Green DA, Srinivas N, Watz N, Tenover FC, Amieva M, Banaei N. A pediatric case of New Delhi metallo-beta-lactamase-1-producing Enterobacteriaceae in the United States. Pediatr Infect Dis J. 2013;32(11):1291-1294.
54. Mochon AB, Garner OB, Hindler JA, et al. New Delhi metallo-beta-lactamase (NDM-1)-producing Klebsiella pneumoniae: case report and laboratory detection strategies. J Clin Microbiol. 2011;49(4): 1667-1670.
55. Rogers BA, Sidjabat HE, Silvey A, et al. Treatment options for New Delhi metallo-beta-lactamase-harboring Enterobacteriaceae. Microb Drug Resist. 2013;19(2):100-103.
56. Hoang TH, Wertheim H, Minh NB, et al. Carbapenem-resistant Escherichia coli and Klebsiella pneumoniae strains containing New Delhi metallo-beta-lactamase isolated from two patients in Vietnam. J Clin Microbiol. 2013;51(1):373-374.
57. McDermott H, Morris D, McArdle E, et al. Isolation of NDM-1-producing Klebsiella pnemoniae in Ireland, Jul 2011. Euro Surveill. 2012;17(7):20087.
58. Carvalho-Assef AP, Pereira PS, Albano RM, et al. Isolation of NDM-producing Providencia rettgeri in Brazil. J Antimicrob Chemother. 2013;68(12):2956-2957.
59. Waterman PE, McGann P, Snesrud E, et al. Bacterial peritonitis due to Acinetobacter baumannii sequence type 25 with plasmid-borne New Delhi metallo-beta-lactamase in Honduras. Antimicrob Agents Chemother. 2013;57(9):4584-4586.
60. Lai CC, Lin TL, Tseng SP, et al. Pelvic abscess caused by New Delhi metallo-beta-lactamase-1-producing Klebsiella oxytoca in Taiwan in a patient who underwent renal transplantation in China. Diagn Microbiol Infect Dis. 2011;71(4):474-475.
61. Peirano G, Ahmed-Bentley J, Woodford N, Pitout JD. New Delhi metallo-beta-lactamase from traveler returning to Canada. Emerg Infect Dis. 2011;17(2):242-244.
62. Barrios H, Silva-Sanchez J, Reyna-Flores F, et al. Detection of a NDM-1-producing Klebsiella pneumoniae (ST22) clinical isolate at a pediatric hospital in Mexico. Pediatr Infect Dis J. 2014;33(3):335.
63. Mulvey MR, Grant JM, Plewes K, Roscoe D, Boyd DA. New Delhi metallo-beta-lactamase in Klebsiella pneumoniae and Escherichia coli. Canada. Emerg Infect Dis. 2011;17(1):103-106.
64. Poirel L, Benouda A, Hays C, Nordmann P. Emergence of NDM-1-producing Klebsiella pneumoniae in Morocco. J Antimicrob Chemother. 2011;66(12):2781-2783.
65. Khajuria A, Praharaj AK, Kumar M, Grover N. A case of septicemia due to Chryseobacterium indologenes producing blaNDM-1. Avicenna J Med. 2014;4(3):71-73.